Ownership history in MORGAN STANLEY · 32 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in SCPHARMACEUTICALS INC (SCPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,672,825 | -475,061 | -22.1% | 0.00% | $9.5M | — |
| 2025 Q2 | ADDED | 2,147,886 | +261,745 | +13.9% | 0.00% | $8.2M | — |
| 2025 Q1 | REDUCED | 1,886,141 | -23,947 | -1.3% | 0.00% | $5.0M | — |
| 2024 Q4 | ADDED | 1,910,088 | +1,577,434 | +474.2% | 0.00% | $6.8M | — |
| 2024 Q3 | ADDED | 332,654 | +111,363 | +50.3% | 0.00% | $1.5M | — |
| 2024 Q2 | ADDED | 221,291 | +40,571 | +22.4% | 0.00% | $963K | — |
| 2024 Q1 | REDUCED | 180,720 | -17,866 | -9.0% | 0.00% | $907K | — |
| 2023 Q4 | REDUCED | 198,586 | -936,993 | -82.5% | 0.00% | $1.2M | — |
| 2023 Q3 | REDUCED | 1,135,579 | -25,786 | -2.2% | 0.00% | $8.1M | — |
| 2023 Q2 | REDUCED | 1,161,365 | -6,196 | -0.5% | 0.00% | $11.8M | — |
As of 2025 Q3 — sorted by position size